Literature DB >> 6273712

Superpotency and superaffinity phenomena in the stimulation of steroidogenesis in adrenocortical cells by adrenocorticotropin-tobacco mosaic virus conjugates.

V M Kriwaczek, A F Bristow, A N Eberle, C Gleed, D Schulster, R Schwyzer.   

Abstract

Adrenocorticotropin-(1-24)-tetracosapeptide was covalently attached to tobacco mosaic virus in two different manners: (i) through a handle near the C-terminus on tyrosine-(23) and (ii) through a handle at the N-terminus on serine-(1). Compounds of type (i) with their N-terminal message sequence freely exposed on the virion surface were considerably more potent for stimulating steroidogenesis in isolated adrenocortical cells than those of type (ii) with a more congested message. Conjugates with 50 or less hormone molecules per virion were less potent per peptide unit than the "free" handle-substituted hormones, whereas conjugates with 150 ACTH units exhibited superpotency effects. Superpotency disappeared when the substituted virions were disaggregated into (substituted) capsomers, suggesting influences of hormone clustering and virion geometry on biological activity. Superpotent stimulation was irreversible under conditions that immediately inhibited steroidogenesis by ACTH (dilution, addition of a peptide antagonist). Thus, superpotency might be caused by superaffinity arising from a slow rate of dissociation of the conjugates from the target cell receptors. The reason for the slow dissociation rate is still unclear: possible explanations include cooperative affinity, rapid internalization of the conjugate-receptor complexes, or decreased rates of peptide degradation at the receptor site.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273712     DOI: 10.1007/bf00230187

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  12 in total

1.  ACTH: a short introductory review.

Authors:  R Schwyzer
Journal:  Ann N Y Acad Sci       Date:  1977-10-28       Impact factor: 5.691

2.  [Specific covalent attachment of adrenocorticotropin and angiotensin II derivatives to polymeric matrices for use in affinity chromatography (author's transl)].

Authors:  J L Fauchère; G M Pelican
Journal:  Helv Chim Acta       Date:  1975-11-05       Impact factor: 2.164

3.  Effects of ACTH (corticotropin) analogues on steroidogenesis and cyclic AMP in rat adrenocortical cells. Evidence for two different steroidogenically responsive receptors.

Authors:  A F Bristow; C Gleed; J L Fauchère; R Schwyzer; D Schulster
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

4.  Multi-subsite receptors for multivalent ligands. Application to drugs, hormones, and neurotransmitters.

Authors:  A De Lean; P J Munson; D Rodbard
Journal:  Mol Pharmacol       Date:  1979-01       Impact factor: 4.436

5.  Corticosteroidogenesis in isolated adrenal cells: effect of adrenocorticotrophic hormone, adenosine 3',5'-monophosphate and 1-24 adrenocorticotrophic hormone diazotized to polyacrylamide.

Authors:  M C Richardson; D Schulster
Journal:  J Endocrinol       Date:  1972-10       Impact factor: 4.286

6.  The interaction of hapten-coupled bacteriophage phi-X-174 with antihapten antibody.

Authors:  C L Hornick; F Karush
Journal:  Isr J Med Sci       Date:  1969 Mar-Apr

7.  Polar uncoating of tobacco mosaic virus (TMV) with dimethylsulfoxide (DMSO) and subsequent reassembly of partially stripped TMV.

Authors:  A Nicolaïeff; G Lebeurier
Journal:  Mol Gen Genet       Date:  1979-03-27

8.  Preparation and some properties of maleimido acids and maleoyl derivatives of peptides.

Authors:  O Keller; J Rudinger
Journal:  Helv Chim Acta       Date:  1975-03-12       Impact factor: 2.164

Review 9.  Structure and function in neuropeptides.

Authors:  R Schwyzer
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-10-29

10.  Tobacco mosaic virus-enkephalin conjugates: potentiation of opioid activity.

Authors:  V M Kriwaczek; R Schwyzer; M G Gillan; S J Paterson; H W Kosterlitz
Journal:  Peptides       Date:  1981       Impact factor: 3.750

View more
  2 in total

Review 1.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

2.  Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors.

Authors:  S D Sharma; J Jiang; M E Hadley; D L Bentley; V J Hruby
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.